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Abstract
Objective The association between cigarette smoking and
colorectal cancer (CRC) is still not established. In 2002,
Norwegian women had the second highest incidence of CRC
intheworld.AlargeproportionofNorwegianwomenareever
smokers. We examined the association between cigarette
smoking and CRC incidence among Norwegian women.
Methods We followed 68,160 women, aged 30–69 years,
from the Norwegian Women and Cancer Study who
completed a questionnaire in 1996 or 1998 by linkages to
national registers through 31 December 2005. Rate ratios
(RRs) and 95% conﬁdence intervals (CIs) were estimated
by ﬁtting Cox proportional hazard models. Subsequently,
we estimated the population attributable fraction.
Results Altogether, 425 incident cases of primary, inva-
sive CRC were identiﬁed. Ever smokers had a 20%
increased risk of CRC (RR = 1.2; 95% CI = 1.0–1.5), a
30% increased risk of colon (RR = 1.3; 95% CI = 1.0–
1.7), and a 10% increased risk of rectal (RR = 1.1; 95%
CI = 0.7–1.5) cancer compared to never smokers. The
population attributable fraction was estimated to be 12%
which indicated that approximately one in eight of the CRC
cases could have been prevented at a population level.
Conclusion Our results support the hypothesis that ciga-
rette smoking is a preventable cause of CRC among women.
Keywords Colorectal cancer   Cigarette smoking  
Cohort study   Women   Norway
Introduction
The association between cigarette smoking and colorectal
cancer (CRC) is not established. In Norway, CRC is the
second most common cancer found after prostate cancer
among men and breast cancer among women with a total of
1,767 incident cases among women in 2006 [1]. For both
genders, the age adjusted incidence rate of CRC has been
doubled during the last 50 years. In 2002, Norwegian
women had the second highest incidence of CRC in the
world, only surpassed by women in New Zealand [2].
There has been, so far, no obvious explanation for the
increase in risk and top ranking among Norwegian women
[3]. Worldwide CRC is one of the most common cancers
with a high mortality [2].
In 1996, Giovannucci et al. [4] hypothesized that
smoking is an initiator of colorectal carcinogenesis, but
that the increased risk only emerges 30–40 years after the
smoking initiation. The notion that smoking is a risk factor
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reports from 2004, one from the International Agency for
Research on Cancer [6] and the other from the US Surgeon
General [7], found that there was not enough evidence to
conclude that the relationship between smoking and CRC
is causal. Because the use of tobacco is rising globally
among women [8, 9] smoking may result in large numbers
of CRCs if a causal association exists.
For more than 30 years, from the late 1960s until the
year 2000, the prevalence of daily, current smokers was
more than 30% among Norwegian women. In 2005, daily
smokers represented 40% among those with only primary
school education [10]. A large proportion of Norwegian
women are ever smokers, i.e., either current or former
smokers. Data on smoking and CRC from prospective
studies are still sparse. The purpose of this study was to
examine the association between cigarette smoking and
CRC incidence, overall and by location, in a countrywide,
and population-based, prospective cohort study. Subse-
quently, we estimated the number of avoidable CRCs if no
Norwegian women had smoked.
Materials and methods
Study population—The Norwegian Women and Cancer
(NOWAC) study
As previously documented [11, 12] the NOWAC study is a
prospective, country wide, and population-based cohort
study comprising a representative sample of the Norwegian
female population. All women were randomly selected
from the Central Population Register according to year of
birth. A letter of invitation to participate in the study
contained a questionnaire and a pre-stamped return enve-
lope. The National Data Inspectorate and the Regional
Committee for Medical Research Ethics approved the
study. All women gave an informed consent.
The NOWAC study was initiated in 1991 recruiting
57,600 women aged 34–49 years (response rate 57.6%) who
answered a postal questionnaire. In 1996, women aged 30–
69 were invited to respond to a postal questionnaire. The
cohort expanded with 44,843 women (56.8% of the sub-
jects). In 1998, a similar postal questionnaire was mailed to
the initial sub-sample, of whom 46,971 women (81.5%)
responded. More details about the study population may be
found elsewhere [11, 12]( http://uit.no/kk/NOWAC/).
Exposure information
The questionnaire included detailed assessment of smoking
habits, hormonal contraceptive use, postmenopausal hor-
mone therapy (HT) use, physical activity (PA), and other
lifestyle habits as well as height and current weight
(allowing us to calculate body mass index (BMI) as weight
in kilograms divided by the square of height in meters). It
also comprised 82 different food frequency questions
including alcohol consumption and dietary supplements.
The questionnaires asked if the women have ever been
smoking, and those answering ‘‘yes’’ were asked for
number of cigarettes smoked daily at different age inter-
vals. Subsequently, they were asked if they smoke on a
daily basis at the moment. We categorized ever smokers
according to current and former smoking status, age at
smoking initiation, smoking duration, average number of
cigarettes smoked daily, pack-years of smoking (i.e.,
number of cigarettes smoked per day, divided by 20,
multiplied by the number of years smoked), and latency
(i.e., age at enrolment in the study minus age at smoking
initiation) all at enrolment. Former smokers were classiﬁed
according to years since quitting smoking. All women not
being current or former smokers were classiﬁed as never
smokers.
Women who reported a natural menopause or a bilateral
oophorectomy at cohort enrolment were considered post-
menopausal during follow-up. All other women were
considered pre-menopausal, regardless of age, hysterec-
tomy, or use of postmenopausal HT. We calculated average
daily consumption of alcohol in grams based on the content
of pure alcohol in different sorts of beverages among
drinkers. Women who reported to be teetotallers and those
answering ‘‘seldom’’ or ‘‘never’’ in the frequency table had
their alcohol consumption set to zero.
Follow-up and endpoints
The study population comprised women, aged 30–69 years,
who completed a questionnaire in 1996 together with the
responders of the second questionnaire in 1998, for a total of
91,814women.Wefollowedthewomenwithlinkagestothe
Cancer Registry of Norway and the Central Population
Register, utilizing the unique national birth number to
identify all cancer cases and deaths/emigrations, respec-
tively. The national registries are both accurate and virtually
complete [13]. Woman-years were calculated from the start
of follow-up to the date of diagnosis of CRC, the date of any
incidentcancer(exceptskinbasalcellcarcinoma)diagnosis,
emigration,death,ortheendoffollow-up,i.e.,31December
2005, whichever occurred ﬁrst.
The colorectal tumors were classiﬁed according to the
Seventh Revision of the International Statistical Classiﬁ-
cation of Diseases. Women with colon cancer were further
categorized according to location of the tumors proximal
(codes 153.0/153.1) and distal (codes 153.2/153.3) colon
cancers. Tumors that were overlapping (code 153.4),
speciﬁed as appendix (code 153.6), or unspeciﬁed (code
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analyses for the whole colon only.
We excluded 3,734 subjects who were diagnosed with
any invasive cancer prior to the start of the study, 17
women who had emigrated or died, one woman with
missing vital status, 2,264 women with insufﬁcient infor-
mation on smoking history, leaving 85,798 women.
Altogether 17,638 women, including 116 cases, with
missing information for any of the covariates considered
a priori as relevant were excluded from the multivariate
models. The study population comprised the remaining
68,160 women.
Statistical analysis
We calculated crude CRC incidence rates by dividing the
number of cases by the total number of woman-years in
that exposure category. The rates were then age-adjusted to
the world standard population [14]. Rate ratios (RRs) and
95% conﬁdence intervals (CIs) associated with different
measures of smoking exposure for CRC overall, and
according to location, i.e., in proximal- or distal colon or in
rectum, were estimated by ﬁtting Cox proportional hazards
models [15] with never smokers as the reference group.
The RR of each of the following factors was estimated
in both univariate and multivariate analyses and evaluated
as a potential confounder of the relation between cigarette
smoking and CRC: age (years, continuous), education
(years, continuous), menopausal status (pre, post), both
current and ever user of hormonal contraceptive (yes, no),
ever user of postmenopausal HT (yes, no), mean recrea-
tional and work related PA score on a 10-level scale (1–
10), BMI (continuous), and alcohol consumption (grams/
day), all at enrolment. Several additional dietary factors,
i.e., meat, fruit, vegetables, ﬁber, calcium, and folate, were
also evaluated, but none were related to CRC in this cohort
and therefore not kept in the ﬁnal analyses.
Factors changing the RR estimate with 5% were inclu-
ded in the ﬁnal multivariate models, i.e., age, menopausal
status, ever user of hormonal contraceptive, ever user of
postmenopausal hormone therapy, BMI, and alcohol con-
sumption. The Cox analyses were performed with the
PHREG procedure in the SAS statistical package [16].
Tests for linear trend were obtained by creating an ordinal
exposure variable with equally spaced scores and including
it in the models. The population attributable fraction (PAF)
was calculated using the formula PAF ¼
PeðRRe 1Þ
Pe  RRe þð1 PeÞ
quoted in Breslow and Day [17], where the notation
Pe = The proportion of persons in the population exposed
to the risk factor and RRe = The relative risk in the
exposed group compared to the unexposed. All statistical
tests were two-sided and were considered statistically sig-
niﬁcant at p B 0.05. Finally, we rerun the main analyses in
the ﬁnal models excluding the cases (n = 38) which
occurred during the ﬁrst year and also including a category
for missing values for each of the covariates. The results
did not materially change (data not shown).
Results
During the 533,786 woman-years of observation, 425
incident cases of histologically conﬁrmed primary invasive
colorectal [284 (67%) colon and 141 (33%) rectal] cancers
were identiﬁed. Among the colon tumors 137 (48%) were
classiﬁed as proximal, 108 (38%) as distal, and the
remaining 39 (14%) cases as ‘‘others.’’ Altogether, 43,578
(64%) of the women reported to have been ever smokers of
which approximately one half (51%) reported being current
smokers. The proportion of women with a latency period of
30 or more years was higher among the former (62%)
compared with the current (59%) smokers (p\0.05).
Table 1 shows the distribution of selected characteristics
at enrolment among cases and non-cases, and according to
anatomical distribution of tumors. The cases were older
and less educated, and were more likely to be post-meno-
pausal. They were less likely to have a history of ever use
of hormonal contraceptive and more likely to have used
postmenopausal hormonal therapy compared with non-
cases (all p values \0.05). There was no difference
between colon and rectal cancer cases or between proximal
and distal colon cancer cases for the variables displayed in
the table (Table 1).
Table 2 shows that the distribution of the selected
characteristics varies according to the women’s smoking
status. Current smokers differed from never smokers on all
the listed variables in Table 2 (all p values\0.001), except
for height. The age-adjusted incidence rates of CRC were
83 and 65 per 100,000 woman-years among ever and never
smokers, respectively.
Table 3 shows the multivariate RR estimates of CRC
overall and separately for colon and rectal cancers among
ever smokers, compared with never smokers. Former
smokers had a 30% increased risk for CRC (RR = 1.3;
95% CI = 1.0–1.6) and a 40% increased risk of colon
tumors (RR = 1.4; 95% CI = 1.1–1.9), whereas only non-
signiﬁcantly increased risks were found for current smok-
ers. When the two groups were collapsed, ever smokers
had a 20% increased risk of CRC (RR = 1.2; 95%
CI = 1.0–1.5), a 30% increased risk of colon cancer
(RR = 1.3; 95% CI = 1.0–1.7), and a non-signiﬁcantly
increased risk of rectal (RR = 1.1; 95% CI = 0.7–1.5)
cancers, compared with never smokers. Ever smokers with
a latency period of more than 40 years had a similar 30%
increased risk for colorectal (RR = 1.3; 95% CI = 1.0–
1.7), colon (RR = 1.3; 95% CI = 0.9–1.8), and rectal
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123Table 1 Distribution of selected characteristics
a of the study population (n = 68,160) at cohort enrolment among cases, non-cases and
according to tumor localization
Characteristics Colorectal
cancer
n = 425
Non-cases
n = 67,735
p-value
b Colon
cancer
n = 284
Rectal
cancer
n = 141
p-value
c Colon
cancer proximal
n = 137
Colon
cancer distal
n = 108
p-value
d
Age at enrolment (year) 55.9 49.7 \0.0001 56.1 55.5 0.4 57.3 55.6 0.1
Age at diagnosis (year) 60.7 – – 61.0 60.1 0.3 61.9 60.7 0.2
Person years follow-up 4.6 7.9 \0.0001 4.7 4.4 0.4 4.5 4.9 0.2
Education (year) 10.9 11.9 \0.0001 10.7 11.3 0.1 10.3 10.7 0.4
Post-menopausal at enrolment 62.6 35.7 \0.0001 62.7 62.4 1.0 64.2 64.8 0.9
Ever HC use (%) 42.4 55.9 \0.0001 39.1 48.9 0.0530 38.0 41.7 0.6
Ever PM HT use (%) 34.4 27.3 0.0012 36.6 29.8 0.2 38.0 38.0 1.0
Mean PA score
e 5.4 5.5 0.4 5.4 5.3 0.9 5.2 5.6 0.2
Body height 166.0 166.1 0.7 165.8 166.6 0.1 165.2 165.7 0.5
BMI
f at enrolment 24.5 24.5 0.8 24.4 24.7 0.4 24.9 24.2 0.2
Teetotallers (%) 12.5 10.6 0.2 14.4 8.5 0.1 14.6 14.8 1.0
Alcohol consumption (g/day)
g 3.8 3.8 1.0 3.8 3.8 1.0 3.5 4.1 0.3
Abbreviations: HC Hormonal contraceptive, PM Post-menopausal, HT Hormone therapy, PA Physical activity, BMI Body mass index
a Given as mean unless otherwise speciﬁed
b T-test or chi-square test for differences between cases and non-cases
c T-test or chi-square test for differences between colon and rectal cancer cases
d T-test or chi-square test for differences between proximal and distal colon cancer cases
e Mean recreational and work related physical activity score on a 10-level scale (1–10)
f Body mass index; weight in kilograms divided by the square of the heights in meters
g Among drinkers, g/day = gram per day
Table 2 Distribution of selected characteristics
a of the study population (n = 68,160) at cohort enrolment according to smoking status
Characteristics Current smokers
n = 22,077
Former smokers
n = 21,501
Never smokers
n = 24,582
p-value
b
Age at enrolment (year) 48.7 49.7 50.7 \0.0001
Age at diagnosis (year) 59.5 60.5 61.9 0.0206
Education (year) 11.2 12.1 12.5 \0.0001
Post-menopausal at enrolment 35.0 33.9 38.5 \0.0001
Age at menopause (year)
c 47.3 48.4 49.0 \0.0001
Ever HC use (%) 62.3 59.2 47.0 \0.0001
Ever PM HT use (%) 28.6 28.8 25.0 \0.0001
Mean PA score
d 5.4 5.5 5.5 \0.0001
Height (cm) 166.1 166.3 166.0 0.1
BMI at enrolment
e 23.9 24.8 24.7 \0.0001
Teetotallers (%) 5.2 6.2 19.5 \0.0001
Alcohol consumption (g/day)
f 4.1 4.1 3.2 \0.0001
Abbreviations: HC Hormonal contraceptive, PM Post-menopausal, HT Hormone therapy, PA Physical activity, BMI Body mass index
a Given as mean unless otherwise speciﬁed
b T-test or chi-square test for differences between current and never smokers
c Among women that were postmenopausal at enrolment
d Mean recreational and work related physical activity score on a 10-level scale (1–10)
e BMI = the weight in kilograms divided by the square of the heights in meters)
f Among drinkers
898 Cancer Causes Control (2009) 20:895–903
123(RR = 1.3; 95% CI = 0.8–2.1) cancers. The displayed RR
estimates for smoking initiation (C20 and \20 years),
number of pack-years smoked (0–9, 10–19, and C20), and
duration of smoking (number of years smoked (1–19, 20–
29, and C30)) showed a signiﬁcant dose response associ-
ation with colorectal tumors when a category for never
smokers was included in the trend test (all p values\0.05),
whereas the number of cigarettes smoked per day did not
(p = 0.14). Similar signiﬁcant results were found for colon
cancer, while none of the trend tests achieved statistical
signiﬁcance for rectal cancer. The RR estimates for rectal
cancer in the upper exposure categories (latency C40,
smoking initiation \20; number of pack-years C20, and
number of years smoked C30) were all increased, although
Table 3 Multivariate
a rate ratios estimates and 95% conﬁdence intervals of colorectal cancer overall, and by location among ever smokers
according to various measures of smoking exposure at enrolment compared with never smokers among 68,160 women
Colorectal cancer n = 425 Colon cancer n = 284 Rectum cancer n = 141
Cases/cohort RR 95% CI Cases RR 95% CI Cases RR 95% CI
Smoking status
Never 150/24,582 1.0 Ref 97 1.0 Ref 53 1.0 Ref
Former 147/21,501 1.3 (1.0–1.6) 107 1.4 (1.1–1.9) 40 0.9 (0.6–1.4)
Current 128/22,077 1.2 (0.9–1.5) 80 1.1 (0.8–1.6) 48 1.2 (0.8–1.8)
Ever 275/43,578 1.2 (1.0–1.5) 187 1.3 (1.0–1.7) 88 1.1 (0.7–1.5)
Ever smokers
Smoking initiation
C20 140/17,756 1.2 (0.9–1.5) 98 1.3 (1.0–1.7) 42 1.0 (0.6–1.5)
\20 135/25,822 1.3 (1.0–1.6) 89 1.3 (1.0–1.8) 46 1.2 (0.8–1.8)
p trend
b \0.05 0.05 0.5
Latency (years between smoking initiation and cohort enrolment)
1–29 55/17,249 1.1 (0.8–1.5) 37 1.2 (0.8–1.8) 18 0.9 (0.5–1.5)
30–39 127/21,148 1.2 (0.9–1.5) 88 1.3 (1.0–1.8) 39 1.0 (0.6–1.5)
C40 93/5,181 1.3 (1.0–1.7) 62 1.3 (0.9–1.8) 31 1.3 (0.8–2.1)
p trend
b 0.5 0.9 0.3
Number of cigarettes per day
1–9 165/24,927 1.2 (1.0–1.5) 114 1.3 (1.0–1.7) 51 1.0 (0.7–1.5)
10–14 81/12,900 1.3 (1.0–1.7) 53 1.4 (1.0–1.9) 28 1.2 (0.8–2.0)
C15 29/5,751 1.1 (0.7–1.7) 20 1.2 (0.7–2.0) 9 0.9 (0.4–1.9)
p trend
b 0.14 0.11 0.7
Number of years smoked
1–19 78/15,157 1.1 (0.8–1.5) 55 1.2 (0.9–1.7) 23 0.9 (0.5–1.5)
20–29 66/13,592 1.2 (0.9–1.6) 47 1.4 (1.0–2.0) 19 0.9 (0.5–1.6)
C30 131/14,829 1.3 (1.0–1.6) 85 1.3 (1.0–1.8) 46 1.3 (0.8–1.9)
p trend
b 0.04 0.07 0.3
Number of pack-years smoked
0–9 113/21,609 1.0 (0.8–1.3) 78 1.1 (0.8–1.5) 35 0.9 (0.6–1.3)
10–19 103/14,584 1.5 (1.1–1.9) 75 1.7 (1.2–2.3) 28 1.1 (0.7–1.7)
C20 59/7,385 1.3 (1.0–1.8) 34 1.2 (0.8–1.8) 25 1.5 (0.9–2.5)
p trend
b 0.008 0.03 0.13
Time since quitting smoking (years)
C20 52/6,777 1.1 (0.8–1.5) 36 1.2 (0.8–1.7) 16 0.9 (0.5–1.6)
10–19 46/6,122 1.5 (1.1–2.1) 24 1.7 (1.2–2.6) 5 1.1 (0.6–2.1)
1–9 49/8,602 1.1 (0.8–1.7) 33 1.5 (1.0–2.4) 13 0.5 (0.2–1.3)
0 (Current) 128/22,077 1.2 (1.0–1.5) 84 1.2 (0.9–1.6) 34 1.2 (0.8–1.8)
p trend
b 0.11 0.16 0.5
a Adjusted for age, menopausal status, hormonal contraceptive and postmenopausal hormonal therapy use, BMI and alcohol consumption, all at
enrolment
b Never smokers included in the model
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123not signiﬁcantly. No meaningful association was found
between time since quitting smoking and colorectal tumors
overall or by anatomical subsite (Table 3).
Table 4 shows that a model including 137 proximal and
108 distal colon cancers found that former smokers had a
signiﬁcantly increased risk for both the proximal
(RR = 1.6; 95% CI = 1.1–2.4), and distal (RR = 1.7;
95% CI = 1.1–2.7) colon tumors (Table 4). The PAF was
estimated to be 12%.
Discussion
The results from our study suggest that in Norway one out
of eight CRCs would have been prevented annually if
women had not been smoking. The increased risk of CRC
is found foremost for colon cancer, but is also indicated for
rectal cancer. In support of a causal relationship between
smoking and CRC, our results show a dose–response
relationship between age of smoking initiation, number of
years, and of pack-years smoked. The increase in risk of
CRC caused by smoking seems to require a long latency
period. Thus our results are in accordance with the pre-
vailing hypothesis described previously [4].
Our study has several major strengths. The study is a
countrywide, truly population-based, and a prospective
cohort representing the general female population in Nor-
way. Also, the smoking histories were obtained at
enrolment and, hence, are not subject to recall bias. Our
cohort has virtually complete follow-up and we are able to
examine the association with smoking according to site-
speciﬁc cancer subgroups. We have a high proportion of
both current and former smokers [18, 19], and the smoking
habits found in our study reﬂect known smoking patterns
among Norwegian women [20]. In addition, we have
detailed information on, and are able to control for,
established risk factors for CRC, many of which vary
according to smoking status. CRC screening practices are
not yet common in Norway and are therefore unlikely to
affect our results. Furthermore, the cumulative incidence
rates during follow-up for all cancer sites have been shown
to be almost identical to those reported to the national
cancer registries in Norway during the same period [12].
Since our cohort is representative both according to
exposure and outcome, we can justify our estimation of
PAF due to smoking.
Our study also has several limitations. We have a short
follow-up period resulting in a limited number of cases.
This gives us more unstable estimates, results that are more
prone to chance and we are unable to stratify the analyses
in detail according to different measures of smoking
exposure. Since time of smoking initiation, latency, dura-
tion, and pack-years of smoking are highly correlated; we
cannot separate their effects. We lack information on depth
of inhalation, type of cigarettes smoked, and passive and
occasional smoking status. We assume that women
exposed to passive smoking have been included in the
reference group. Around 10% of the Norwegian female
population reported to be occasional smokers at the period
of our enrolment of whom approximately half were former
daily smokers [20]. We believe that in our study, some of
these women have been excluded due to insufﬁcient
smoking information; some have been included in the
reference group, while those answering ‘‘yes’’ to ever and
‘‘no’’ to current daily smoking have been classiﬁed as
former smokers. Including women exposed to passive
smoking and those who smoke occasionally in the refer-
ence group would have attenuated the associations between
smoking and CRC. Categorizing occasional smokers as
former smokers would most likely have the same effect. A
limitation is that we do not have information on changes in
smoking habits during follow-up. However, few Norwe-
gian women start to smoke after the age of 30, which is the
lowest age of enrolment in our study. We know that current
smokers quit smoking and former smokers reengaged in
smoking [20]. If a large proportion of the ever smoking
women changed exposure category during follow-up, this
would have resulted in an underestimation of the RR
among current and an overestimation of the RR among
former smokers. Since current smokers have an increased
risk of dying from any major cause during follow-up and
CRC is assumed to take many years, competing causes of
Table 4 Multivariate
a rate ratios estimates and 95% conﬁdence intervals for proximal and distal colon cancer according to smoking status
among 68,160 women
Smoking status Proximal colon cancer n = 137 Distal colon cancer n = 108
Cases RR 95% CI Cases RR 95% CI
Never 44 1.0 Ref 36 1.0 Ref
Former 53 1.6 (1.1–2.4) 46 1.7 (1.1–2.7)
Current 40 1.4 (0.9–2.1) 26 1.0 (0.6–1.6)
Ever 93 1.5 (1.0–2.2) 72 1.3 (0.9–2.0)
a Adjusted for age, menopausal status, hormonal contraceptive and postmenopausal hormonal therapy use, BMI and alcohol consumption, all at
enrolment
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123death may decrease the impact of smoking among current
smokers. Both circumstances could explain why the asso-
ciation with CRC is quite similar for current and former
smokers. In the multivariate analysis, alcohol consumption
was the covariant with most impact on the RR estimates.
We lack information on changes regarding the covariates
during the follow-up. There may be some residual con-
founding due to these and other unknown risk factors.
Nevertheless, the dose response observed is suggestive of a
causal association.
In the latest review by the International Agency for
Research on Cancer in 2004 [6], most of the studies
examined for a possible causal relationship between
smoking and risk of CRC did not have the required
hypothesized latency or induction period. The results from
the few previous epidemiological studies ﬁnding weak
positive associations between smoking and CRC have been
explained as confounded by alcohol and other dietary risk
factors [6, 21]. Indeed both, alcohol consumption [22, 23]
and intake of read meat [23] were recently established as
risk factors for CRC.
In Norway, women began smoking in substantial num-
bers in the late 1960s and early 1970s [10]. As a
consequence our cohort study is the ﬁrst in which a high
proportion of Norwegian women could have accrued long
enough induction time for the smoking and CRC rela-
tionship to take place. Nevertheless, a previous study from
Norway, including older cohorts with fewer smoking
women, did ﬁnd a non-signiﬁcant increased risk of both
colon and rectal cancer among former, but not among
current smoking women [24].
It has been suggested that colon and rectal cancer may
have different risk factors [25]. Our results indicate that
smoking is a risk factor for both proximal and distal colon
cancer as well as for rectal cancer. The association is more
consistent for colon cancer, which may be due to the fact
that we had twice as many colon cancers as rectal cancer
cases. We ﬁnd the overall associations to be similar among
former and current smokers. We ﬁnd no association
between time since smoking cessation and risk of CRC.
These results are consistent with the hypothesis that
smoking is an initiator rather than a promoter of CRC [26,
27].
Results from other cohort studies are sparse and some-
what inconsistent, and they do not represent the general
population as ours do. In 1994, Giovannucci et al. [26]
reported that ever smokers in the Nurses’ Health Study had
an increase in risk of both colon and rectal cancer and that
most importantly this increase in risk was not revealed until
35 years after smoking had begun. Using data from the
Canadian National Breast Cancer Study, Terry et al. [28]
found a signiﬁcantly increased risk of rectal cancer, but not
of colon cancer among women with a smoking latency of
more than 40 years. The Iowa Women’s Health Study
found that ever smokers among the postmenopausal
women had an overall increased risk of CRC [29]. In a
recent report examining the participants in the Women’s
Health Initiative study, Paskett et al. [30] found a statisti-
cally signiﬁcant increased risk among the less than seven
percent current smokers for rectal cancer, but not for colon
cancer. Among the approximately 42% former smokers the
results showed a borderline signiﬁcantly increased risk of
12% for colon cancer, and a non-signiﬁcant increased risk
of 15% for rectal cancer.
Two European cohort studies [31, 32], also found an
increased risk for CRC overall. The Swedish study reported
that after examining the relationship by subsite, ever
smokers had a 60% non-signiﬁcant increased risk for colon
(n = 318) and a ﬁvefold increased risk for rectal cancer
which almost all of the 180 cases occurred among the men
[31]. The other study from the UK only included 95 cases
and did not report by subsite [32]. These results were, as
ours, from multivariate analyses adjusting for, among other
factors and intake of alcohol [26, 28–32]. In a recent report
from the US [33], examining two cohorts from 1963 to
1975 with both genders, a non-signiﬁcant increased risk for
rectal cancer was found among women in the most recent
cohort. This study based on data from two private censuses
could only adjust for a few socioeconomic factors.
Some of the case–control studies that show results for
women separately have found a positive relationship
between ever smoking and colon cancer, but not rectal
cancer [34] for rectal, but not colon cancer [35], and for
both [36] cancers. In a systematic review including six
cohort and 15 case–control studies in Japan, the authors
conclude that ever smokers may have an increased risk for
CRC, and particularly for rectal cancer. The few results
displayed for women were in agreement with this [37].
Several recent studies have examined if the relatively weak
association between smoking and CRC is depending on
genetic susceptibility [38] or on molecular aspects of the
tumor [39, 40]. So far no clear pattern has emerged.
Cigarette smoking has been shown to be a precursor for
colorectal adenomas which are established risk factors for
CRC [41, 42]. Cigarette smoke contains a mixture of at least
60 established mutagenic carcinogens including arsenic,
cadmium, ammonia, formaldehyde, and benzopyrene [6].
These and other genotoxic compounds, including polynu-
clear aromatic hydrocarbons, heterocyclic amines,
nitrosamines, and aromatic amines may reach the colorectal
mucosa through direct ingestion orthroughthe blood stream
[27]. Presence of anti-benzo(a)pyrene diolepoxide-DNA
adduct formation in human colon mucosa have been sug-
gested as an evidence of a direct carcinogenic effect on the
colon derived from diet/and or tobacco smoke [43]. Ben-
zo(a)pyrene [B(a)p] is an incomplete combustion product
Cancer Causes Control (2009) 20:895–903 901
123from cigarette smoke that has been shown to have powerful
carcinogenic activity and to act locally. Hecht has recently
published a model for understanding the mechanisms of
tobacco carcinogenesis. This model conceptualizes the
complex pathways that lead to genomic instability and
ultimately to cancer due to persistence of un-repaired DNA
adducts in tissues of people who smoke cigarettes [44, 45].
Theabove listedcarcinogensintobaccosmokeare plausible
risk factors for colorectal carcinogenesis and support the
biological plausibility of a positive association between
smoking and CRC.
The smoking epidemic among women in the last four
decades can explain some of the marked increase in inci-
dence of CRC in Norway. In conclusion, our results
support the hypothesis that cigarette smoking is a pre-
ventable cause of CRC among women.
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